High-dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008.


BACKGROUND High-dose therapy with autologous stem cell support (HDT) has been a treatment option for lymphomas in Norway for 25 years. The purpose of the article was to describe the use of the therapy for lymphomas for the country as a whole and by health region, and to reveal the overall survival rate. METHOD All lymphoma patients ≥ 18 years who received HDT in Norway in the period 1987-2008 are included. Patients, diagnostics and treatment are identified for each hospital. Data for the population base have been retrieved from Statistics Norway. RESULTS Altogether 726 lymphoma patients received HDT in Norway in the period 1987-2008, with an annual average of 0.72 per 100,000 inhabitants. The annual number of treatments increased until 2004 and has since been stable. The average number of treatments per 100,000 inhabitants per year was 0.94 for Northern Norway Health Region, 0.80 for South-Eastern Norway Health Region, 0.58 for Central Norway Health Region and 0.55 for Western Norway Health Region. Early mortality (death within 100 days) was 6%. Ten-year overall survival was 55% (95% CI 51-59%), and Hodgkin's lymphoma had the best survival of the lymphoma groups (p = 0.01). INTERPRETATION The annual number of HDT increased gradually until 2004. The use of the treatment varied according to the patients' place of residence at the time of diagnosis, and was most frequently used for patients belonging to Northern Norway Health Region. More than half of the lymphoma patients are alive ten years after the treatment.

DOI: 10.4045/tidsskr.13.0243

3 Figures and Tables

Citations per Year

Citation Velocity: 7

Averaging 7 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Smeland2013HighdoseTW, title={High-dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008.}, author={Knut Bj\oro Smeland and Cecilie Essholt Kiserud and Grete Fossum Lauritzsen and Anne Kirsti Blystad and Unn Merete Fagerli and \Oystein Fluge and Alexander Foss{\aa} and Jens Hammerstr\om and Arne Kolstad and Jon H. Loge and Martin Maisenh\older and Bj\orn \Ostenstad and Stein O. Kval\oy and Harald H. Holte}, journal={Tidsskrift for den Norske l{\ae}geforening : tidsskrift for praktisk medicin, ny r{\ae}kke}, year={2013}, volume={133 16}, pages={1704-9} }